Format

Send to

Choose Destination
See comment in PubMed Commons below
ASAIO J. 2013 Jul-Aug;59(4):448-9. doi: 10.1097/MAT.0b013e3182937a65.

Bivalirudin for treatment of aortic valve thrombosis after left ventricular assist device implantation.

Author information

1
Department of Heart Failure and Transplant, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas 77030, USA.

Abstract

Ventricular assist devices are increasingly being used for mechanical support in patients with advanced heart failure. However, thromboembolism remains a leading cause of mortality in this population. We describe the successful treatment of native aortic valve thrombosis with bivalirudin in a patient with factor V Leiden mutation, who had undergone left ventricular assist device implantation, preventing the need for further surgical intervention.

PMID:
23820287
DOI:
10.1097/MAT.0b013e3182937a65
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Support Center